Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
06/2005
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/28/2005US6911595 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/23/2005WO2005056719A1 Organic element for electroluminescent devices
06/23/2005WO2005056532A1 Indazole derivatives which interact with the g-protein coupled receptor family
06/23/2005WO2005056508A1 Method for the production of tetrahydrogeranylacetone
06/23/2005WO2005056015A1 Substituted piperazines
06/23/2005WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
06/23/2005WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
06/23/2005US20050137402 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds
06/23/2005US20050137243 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137195 Thermodynamically stable
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/23/2005US20050137187 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke
06/23/2005US20050137143 Such as 3-( beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)-methyl]-1-isopropyl-5-methylpyrazole; for prevention/treatment of diabetes, diabetic complications, and/or obesity; sodium glucose transport protein inhibitors
06/23/2005CA2548516A1 Pyrazolopyrimidines
06/23/2005CA2548426A1 Substituted piperazines
06/23/2005CA2548262A1 Method for the production of tetrahydrogeranylacetone
06/22/2005EP1542996A2 Octahydro-2-h-naphtho 1,2-f indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
06/22/2005EP1542976A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
06/22/2005EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1542679A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1207295C Method for preparing pyrazo-(4, 3-d) pyrimidine-7-ketone and its intermediate
06/22/2005CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005CA2066304C Pharmaceutical composition for the treatment of autoimmune diseases
06/16/2005WO2005054246A2 Amine derivatives having a tyrosine-kinase-inhibiting effect
06/16/2005WO2005054232A1 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders
06/16/2005WO2005054204A2 Pharmaceutical compounds that regenerate in vivo
06/16/2005WO2005054181A1 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto
06/16/2005WO2005054180A1 Antiamyloid phenylsulfonamides: n-cycloalkylcarboxamides derivatives
06/16/2005WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/16/2005US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
06/16/2005US20050131050 Reacting ethyl trifluoroacetate with 4'fluoroacetophenone and 4-sulphonamidophenyl hydrazine
06/16/2005US20050131049 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
06/16/2005US20050131044 Small molecule inhibitors of necrosis
06/16/2005US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130966 Sodium channel modulators
06/16/2005US20050130957 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/16/2005CA2547248A1 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
06/15/2005EP1541561A1 Pyrazole derivatives and process for the production thereof
06/15/2005EP1539753A2 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
06/15/2005EP1539705A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005CN1626540A Iridium compound and organic electroluminescent device using the same
06/15/2005CN1626520A Compound in alpha (pyrazole formyloxy) acetanilide class of possessing fungicidal property
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/14/2005US6906196 Antiinflammatory agents, rheumatic disorders
06/14/2005US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism
06/14/2005US6906070 Anticoagulants
06/14/2005US6906006 Applying to plants, environment
06/14/2005US6905804 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
06/09/2005WO2005051954A2 PROCESSES FOR THE PREPARATION OF PYRAZOLO[1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF
06/09/2005WO2005051941A1 Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
06/09/2005WO2005051919A1 Aminopyrazole derivatives as gsk-3 inhibitors
06/09/2005WO2005051918A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds
06/09/2005WO2005051917A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051901A1 Anti-cancer agents
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050123849 Electrophotographic organophotoreceptors with novel charge transport materials
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050123795 Having a phosphorescent light emitting layer containing an organometallic complex with Iridium, Rhodium, Osmium, Platinumt, or Palladium and a fused pyrazole or imidazole compound
06/09/2005CA2546652A1 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2544519A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1538138A1 Substituted benzanilide compound and pest control agent
06/08/2005EP1537097A2 Method for preparing 3-halo-4,5-dihydro-1 i h /i -pyrazoles
06/08/2005EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
06/08/2005EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005EP1019045B1 Antithrombotic agents
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/08/2005CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals